These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3245234)

  • 1. Microbial models of mammalian metabolism: production of novel alpha-diketone metabolites of warfarin and phenprocoumon using Aspergillus niger.
    Rizzo JD; Davis PJ
    Xenobiotica; 1988 Dec; 18(12):1425-37. PubMed ID: 3245234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9.
    He M; Korzekwa KR; Jones JP; Rettie AE; Trager WF
    Arch Biochem Biophys; 1999 Dec; 372(1):16-28. PubMed ID: 10562412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation of the enantiomers of phenprocoumon and warfarin by high-performance liquid chromatography using a chiral stationary phase. Determination of the enantiomeric ratio of phenprocoumon in human plasma and urine.
    de Vries JX; Völker U
    J Chromatogr; 1989 Aug; 493(1):149-56. PubMed ID: 2778004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation of phenprocoumon in the rat.
    Pohl LR; Haddock RE; Trager WF
    J Med Chem; 1975 May; 18(5):519-23. PubMed ID: 1151963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the metabolic profiles of R- and S-warfarin and R- and S-phenprocoumon as a probe to categorize the effect of inducing agents on microsomal hydroxylases.
    Porter WR; Wheeler C; Trager WF
    Biochem Pharmacol; 1981 Nov; 30(22):3099-104. PubMed ID: 7337727
    [No Abstract]   [Full Text] [Related]  

  • 6. Microbial models of mammalian metabolism: biotransformations of phenacetin and its O-alkyl homologues with Cunninghamella species.
    Reddy CS; Acosta D; Davis PJ
    Xenobiotica; 1990 Dec; 20(12):1281-97. PubMed ID: 2075748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of phenprocoumon, warfarin and their monohydroxylated metabolites in human plasma and urine by liquid chromatography-mass spectrometry after solid-phase extraction.
    Ufer M; Kammerer B; Kirchheiner J; Rane A; Svensson JO
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 809(2):217-26. PubMed ID: 15315768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation of turmerones by Aspergillus niger.
    Fujiwara M; Marumoto S; Yagi N; Miyazawa M
    J Nat Prod; 2011 Jan; 74(1):86-9. PubMed ID: 21189039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholestyramine interrupts the enterohepatic circulation of phenprocoumon: a new therapeutic possibility in the treatment of phenprocoumon overdose].
    Meinertz T; Jähnchen E; Gilfrich HJ; Groth U; Jonen HG
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1582-4. PubMed ID: 347787
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans.
    Heimark LD; Toon S; Gibaldi M; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1987 Sep; 42(3):312-9. PubMed ID: 3621786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereochemical aspects of the metabolism of phenprocoumon in rat liver microsomes.
    Wheeler C; Trager WF; Porter WR
    Biochem Pharmacol; 1981 Jul; 30(13):1785-90. PubMed ID: 7271865
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotransformation of polymethoxylated flavonoids: access to their 4'-O-demethylated metabolites.
    Buisson D; Quintin J; Lewin G
    J Nat Prod; 2007 Jun; 70(6):1035-8. PubMed ID: 17559266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of cimetidine on action of phenprocoumon.
    Harenberg J; Zimmermann R; Staiger C; de Vries JX; Walter E; Weber E
    Eur J Clin Pharmacol; 1982 Oct; 23(4):365-7. PubMed ID: 7173307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectroscopic study of the interaction of coumarin anticoagulant drugs with polyvinylpyrrolidone.
    Otagiri M; Imai T; Koinuma H; Matsumoto U
    J Pharm Biomed Anal; 1989; 7(8):929-35. PubMed ID: 2490102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformations of selected 3-substituted 4-hydroxycoumarins in solution by nuclear magnetic resonance. Warfarin and phenprocoumon.
    Valente EJ; Porter WR; Trager WF
    J Med Chem; 1978 Feb; 21(2):231-4. PubMed ID: 621721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of induction and inhibition of drug metabolism on pharmacokinetics and anticoagulant activity of the enantiomers of phenprocoumon in rats.
    Schmidt W; Trenk D; Jähnchen E
    Pharmacology; 1980; 21(5):313-22. PubMed ID: 7433511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on interactions between pirprofen and phenprocoumon].
    Marbet GA; Duckert F; Schönenberger PM
    Fortschr Med; 1985 Feb; 103(SPEC NO 7A):207-9. PubMed ID: 3872834
    [No Abstract]   [Full Text] [Related]  

  • 18. Microbial models of mammalian metabolism: stereoselective metabolism of warfarin in the fungus Cunninghamella elegans.
    Wong YW; Davis PJ
    Pharm Res; 1989 Nov; 6(11):982-7. PubMed ID: 2594692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy.
    Vorum H; Honoré B
    J Pharm Pharmacol; 1996 Aug; 48(8):870-5. PubMed ID: 8887741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic fate of phenprocoumon in humans.
    Toon S; Heimark LD; Trager WF; O'Reilly RA
    J Pharm Sci; 1985 Oct; 74(10):1037-40. PubMed ID: 4078699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.